Clinical Trial: HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801235) titled 'HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)' on Jan. 14.

Brief Summary: This is an international multi-centre, non-inferiority phase III randomized controlled trial comparing concurrent chemoradiation with high dose cisplatin (Arm A) vs. hyperfractionated radiation therapy (Arm B) in patients with head and neck squamous cell carcinoma.

Study Start Date: Aug. 20

Study Type: INTERVENTIONAL

Condition: Head and Neck (HNSCC)

Intervention: RADIATION: 70 gy 35 fractions/7weeks+high dose of cisplatin

70 Gy 35 fractions/7weeks+high dose of cisplatin

RADIATION: 81.6 Gy /68 fract...